Laurus Labs

Laurus Labs Limited
TypePublic
NSE: LAURUSLABS
BSE: 540222
IndustryPharmaceuticals
Founded2005 (2005)
FounderSatyanarayana Chava
Headquarters,
India
Number of locations
6
Area served
Global
Key people
    • Satyanarayana Chava (CEO)
    • Vantaram Venkata Ravi Kumar (CFO)
ProductsFormulations
Active pharmaceutical ingredients Speciality Chemicals, Agro Chemicals
ServicesCustom synthesis
Contract development and manufacturing organization
Fermentation
RevenueIncrease ₹6,040 crore (US$630 million) (FY23)
Decrease ₹796 crore (US$83 million) (FY23)
Number of employees
5,700 (2022)
SubsidiariesLaurus Synthesis
Websitewww.lauruslabs.com

Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients (APIs), generic formulations, custom synthesis (CDMO), biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.

Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States.